Free press releases distribution network?

Agency / Source: General Electric Company

Check Ads Availability|e-mail Article
This article was published free of charge. Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Swedish Government and GE Healthcare Open an Innovation Center for Life Sciences - Swedish biotech BioLamina relies on Testa Center to expand - GEhealthcare.com / GE.com
Swedish Government and GE Healthcare Open an Innovation Center for Life Sciences

 

PRTODAY - Newswire & PRZOOM/ - Uppsala, Sweden, 08/21/2018 - Swedish biotech BioLamina relies on Testa Center to expand - GEhealthcare.com / GE.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Swedish government and GE Healthcare are opening Testa Center - an innovation center in Uppsala, Sweden, to boost the commercialization of new technologies and support manufacturing capabilities in the life sciences sector. The 2500 m2 (27,000 sq. ft.) Testa Center houses four bioprocessing laboratories with GE Healthcare technologies for testing new discoveries for the production of biopharmaceuticals, the world’s fastest-growing class of medicines .

The Swedish government, which has invested around EUR 10 million (SEK 100 million) in Testa Center and has identified life sciences as one of its top five partnership programs, is striving to increase collaboration between the public sector, business and academia to strengthen the country’s competitiveness and innovation capability. Earlier this year, the government opened an office that is fully dedicated to life sciences.

“This impressive test bed, Testa Center, which GE Healthcare chose to develop in partnership with the government promotes innovation, strengthens competitiveness and will help us provide more efficient care in the future. This is important for Sweden and our life sciences strategy, as we are facing tougher health challenges globally. People grow older and chronic and lifestyle-related diseases are increasing. Life sciences is a knowledge-intensive sector with a high growth potential,” says Mikael Damberg, Minister for Enterprise and Innovation.

Swedish biotechnology company BioLamina is the first company to run a project at Testa Center. Biolamina develops and manufactures protein-based reagents, Biolaminins used to create reliable and robust processes to develop therapeutic cells from stem cells. The company recently entered into a collaboration with the pharmaceutical company Novo Nordisk to support the development of new cell therapies targeting Parkinson’s disease, heart failure and loss of vision. BioLamina will use Testa Center to scale-up its production capacity, helping it deliver more reagents to its global customer base.

“With the increasing demand of our high-quality laminins within the cell therapy industry, we need to scale-up our production capacity,” says Kristian Tryggvason, CEO of BioLamina. “Testa Center gives us a unique possibility to do this internally instead of relying on large global contract manufacturers.”

“Testa Center was created to advance innovation, but it also strengthens the life sciences talent pool in Sweden. We can learn from smaller companies with fast and flexible ways of working. Testa Center is a real-life example of a successful public-private-partnership that has brought together many key players in Sweden. The engagement and buzz around the center has been astounding, and I believe that many discoveries will be taken to the real world with the help of Testa Center,” says Lotta Ljungqvist, CEO of GE in the Nordics and CEO of Testa Center.

In addition to the investment coming from the Swedish government through its innovation agency, Vinnova, GE Healthcare has invested around EUR 4.5 million (SEK 45 million) in the center. The other sponsors are the national life sciences facilitator SWElife, Region Uppsala, the industry organization Uppsala BIO, the Swedish Agency for Economic and Regional Growth and the Foundation for Collaboration between the Universities in Uppsala, Business, and the Public Sector (STUNS).

Testa Center is a national and international testbed open to academia, start-ups and industry. It is purpose-built for verifying digital, technical and biological innovations in an authentic production setting. This helps organizations achieve a more time and cost-effective way to reduce the risks of securing industrial Proof-of-Concept, which is vital for later market introduction and sales. The industrial-standard bioprocessing laboratories up to pilot-scale (non-GMP) are mainly based on single-use technologies from GE Healthcare Life Sciences. The center is owned and operated as a non-profit company by GE Healthcare in Uppsala that also provides operational support and expertise for project owners. The project owners retain full control of their intellectual property and data.

About GE Healthcare

GE Healthcare is the $19 billion healthcare business of GE (ge.com | gehealthcare.com). As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: General Electric Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRTODAY - Newswire Distribution Service Visibility Checker

 

Distribution / Indexing: [+] [Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Swedish Government and GE Healthcare Open an Innovation Center for Life Sciences

Non-featured company website links are shown on a random basis
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRTODAY - Newswire Distribution Service and LINK as the source.
 
  For more information, please visit:
Links are available on a random basis for non premium members
|
Contact: Saara Nordenström - GEhealthcare.com 
+46 18 6120611 saara.nordenstrom[.]ge.com
 
Newswire Today - PRZOOM disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.

Pharma/BioTech/Nutrition via RSS
AddThis press release: Swedish Government and GE Healthcare Open an Innovation Center for Life SciencesAdd Pharma/BioTech/Nutrition News to My MSNAdd Pharma/BioTech/Nutrition News to My Yahoo!Add NewswireToday Pharma/BioTech/Nutrition Press Release Headline News to Your Google homepage or Google ReaderAdd NewswireToday - PRZOOM Headline News to FeedBurner

This article was published free of charge. Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read More Articles From General Electric Company / Company Profile



Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

EC Approves Ipsen’s Cabometyx® (cabozantinib) for the Treatment of Hepatocellular Carcinoma in Adults Previously Treated with Sorafenib
Neurent Medical's RF-based Minimally Invasive Rhinitis Therapy Earns Acclaim from Frost & Sullivan
Market Entrants Offering Digitized Mass Spectrometry Solutions Gain a Competitive Edge over Traditional Vendors Finds Frost & Sullivan
FDA Approves Label Update for Genentech’s Rituxan (Rituximab) in Two Rare Forms of Vasculitis
Medtech & Pharma Platform Annual Event Celebrates its 5th Anniversary in Basel
Ipsen to Present New Data from its Oncology Portfolio At The 2018 European Society for Medical Oncology (ESMO) Congress
Arla Foods Ingredients Acclaimed by Frost & Sullivan for its Osteopontin-enriched ingredient, Lacprodan® OPN-10
SCHOTT Teams Up with Smart Skin Technologies
STEMCELL Technologies Signs Exclusive License to Commercialize Human Pluripotent Stem Cell-Derived Kidney Organoid Culture System
BASF Launches Next Generation of Carotenoid Formulations

Reserve This Permanent SPACE

Your LOGO permanently HERE on PRTODAY - Newswire Distribution Service most visited Page start at $295 per month

 
Sponsored Links


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.





Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



 
  ©2014 PRTODAY — Limelon Advertising, Co.
Home | About PRTODAY | Advertise | Contact | Investors | Sitemap | FRANCAIS
newswire, PR free press releases distribution magazines engine news alert newsroom press room breaking news public relations articles company news alerts blogsIt younews.me newswiredistribution ezine younews.asia bizentrepreneur biznewstoday digital business report news market search pr firms pr agencies business reports newswire today distri- bution investor relation successful internet entrepreneur free newswire distribution prtoday freenewswiredistribution.com asianewstoday bizwiretoday newswire pr today
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)